Jounce Therapeutics
Jounce Therapeutics, founded in 2012 and headquartered in Cambridge, Massachusetts, is a clinical-stage immunotherapy company developing therapies that enable the immune system to attack tumors.
Last updated on
About Jounce Therapeutics
Founded
2013Estimated Revenue
$50M-$100MEmployees
51-250Funding / Mkt. Cap
$270MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (65)
